Biotech Pharma

What Biotech Pharma does

Biotech Pharma (legal entity: Biotech Pharma Drug Store L.L.C.) is a Dubai-headquartered specialty pharmaceutical distribution and in-licensing company founded in 2006 by pharmacists and marketing professionals with prior experience at US and European pharmaceutical majors. The company focuses on acquisition and in-licensing of specialty assets across Hematology, Oncology, Autoimmune, Urology, Neurosurgery and Nephrology, marketing of authorized generics, and specialty generic product development. Its portfolio spans roughly 17 SKUs including autoimmune injectables (Metoject PFS / Metojectpen), oncology agents (Bendamustine, Bleomycin, Dacarbazine), hematology products (Cadroxy / Hydroxyurea, Spectrila, Trecondi), urology products (BCG-medac, Mitomycin), neurosurgery diagnostics (Gliolan / 5-ALA), renal dialysis supplements (Calphron, NephPlex Rx), and medical devices (MELCURA HoneyGel, Silverlon, Lubragel).

The company operates across the GCC, Jordan, Yemen and select MENA/South Asian markets with a documented 24-48 hour delivery capability and GDP-compliant cloud-based supply chain network providing end-to-end visibility. A key structural asset is the Centre of Regulatory Excellence (CoRE/MENA), established in Dubai in 2012 jointly with Medac GmbH, which centralizes regulatory affairs, eCTD dossier preparation and lifecycle maintenance across MENA, Turkey, Sri Lanka, India and Pakistan. Distribution combines direct sales to government and private hospitals and clinics with channel partnerships (Glomac Medical GmbH for tender business, ALFA Lab Lebanon for I.V. and dialysis solutions) and exclusive regional agreements with principals including Medac GmbH (since 2007/2008, spanning 15+ years), Boryung (2022 exclusive for UAE), Bioteck SPA (2022 ChondroGrid), and Photonamic (Gliolan).

Revenue mechanics rest on one-time product distribution margins supplemented by professional services revenue from regulatory affairs work and business development / regional representation. Pricing is not publicly disclosed and is negotiated contract-by-contract with healthcare providers and public tender authorities. No app, public API or AI/ML capability is offered; the company is not venture-backed, has no disclosed funding rounds, and operates without a parent company. Headquarters is at Al Ttay, Al Khawaneej, Dubai (P.O. Box 184455), with headcount in the 11-50 range.

Name

Biotech Pharma

Legal name

Biotech Pharma Drug Store L.L.C.

Website

https://biotech-pharma.net

Company type

Private

Founded year

2006

Operating status

Operating

Headcount range

11–50 employees

Short description

Biotech Pharma is a Dubai-based specialty pharmaceutical distributor and in-licensing company serving government and private hospitals and clinics across the GCC, Jordan and Yemen with oncology, hematology, autoimmune, urology, neurosurgery, nephrology and medical device products, supported by an in-house regulatory affairs center.

Ownership category

akta.pro rank

Product category

Specialty Pharmaceutical Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (424210)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Specialty Pharmaceutical Distributors (HLAIAJAB)

akta.pro secondary industries

Immunology & Autoimmune Specialty Pharmaceuticals (HLAIACAB), Nephrology & Urology Specialty Pharmaceuticals (HLAIACAH), Specialty Care Pharmaceuticals (HLAIAAAB)

Keywords

• Specialty pharmaceutical distribution
• Pharmaceutical regulatory affairs
• Oncology hematology products
• Medical device distribution
• Renal dialysis supplements

Headquarters

HQ city

Dubai

HQ country

United Arab Emirates

HQ region

Middle East

Offices1 record

Markets served

GTM type

B2B

Offering type

Hardware or Manufacturing

Cost components

Supply Chain, Personnel, Operations, Marketing or Sales, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical Product Distribution: Distribution and sales of branded and generic pharmaceutical products across multiple therapeutic areas including Oncology, Hematology, Autoimmune, Urology, Neurosurgery, and Nephrology. Products are distributed through authorized generic marketing and specialty generic product development.
2. Regulatory Affairs Services: Multi-disciplinary regulatory affairs services including marketing authorization applications, dossier preparation, national labelling texts, artwork preparation, translations (Arabic/Farsi/French/Urdu/English), lifecycle maintenance, variations, line extensions, renewals, and PSUR submissions for the MENA region.
3. Business Development Services: Regional representation and business development services including market analysis, sales and marketing strategy development, and tender business participation for non-registered medicines in MENA and Asian markets through partnership with Glomac Medical GmbH.

Go-to-market motion3 records

Distribution channels3 records

Marketing channels3 records

Core offering

Biotech Pharma distributes and markets specialty pharmaceutical products across autoimmune, oncology, hematology, urology, neurosurgery, and nephrology therapeutic areas, alongside medical devices, renal dialysis supplements, and general sale products. The company handles in-licensing, authorized generic marketing, regulatory affairs (eCTD dossier preparation), and direct distribution to healthcare providers across the GCC, Jordan, and Yemen, with broader MENA and Asian market access delivered through strategic partners such as Glomac Medical GmbH.

Product overview

Biotech Pharma is a pharmaceutical company offering a diverse portfolio of branded and generic pharmaceutical products across multiple therapeutic categories. The product lineup includes autoimmune treatments (Metoject® PFS and Metojectpen®), oncology medications (Bendamustine, Bleomycin, Dacarbazine), hematology drugs (Cadroxy®, Spectrila®, Trecondi), urology treatments (BCG-medac, Mitomycin), neurosurgery products (Gliolan®/5-ALA), general sale products (ALFALYTE Oral Rehydration Solution), renal dialysis supplements (Calphron®, NephPlex® Rx), and medical devices (MELCURA™ HoneyGel, Silverlon, Lubragel). The company serves the GCC region, Jordan, and Yemen through distribution partnerships and regulatory affairs services.

Differentiator

Problem solved

Functional benefit

Products and services

• Metoject® PFS 50MG/ML Methotrexate-based autoimmune medication supplied in pre-filled syringe form, distributed to healthcare providers for treating rheumatoid arthritis and other autoimmune conditions.
• Metojectpen® 50MG/ML Autoimmune medication delivered via pen injector for convenient self-administration of methotrexate in rheumatoid arthritis and similar conditions.
• Bendamustine Powder for infusion Chemotherapy drug used for infusion treatment in oncology applications, distributed to hospitals and oncology centers.
• Bleomycin Powder for solution for injection 15,000IU Antitumor antibiotic used in cancer treatment regimens, supplied as powder for solution for injection.
• Dacarbazine Powder for injection/infusion 100mg, 200mg, 500mg Chemotherapy agent available in 100mg, 200mg, and 500mg dosage strengths for injection or infusion in oncology.
• Cadroxy®, Hydroxyurea Capsules 500mg Hematology medication (hydroxyurea capsules) for treating sickle cell disease and certain cancers.
• Spectrila® 10,000U (Recombinant Asparaginase) Recombinant enzyme (asparaginase 10,000 IU) used in leukemia treatment, supplied as solution for infusion.
• Trecondi Powder for injection/infusion 1G, 5G Hematology product (treosulfan) for injection/infusion, available in 1G and 5G dosage forms.
• BCG-medac Powder and solvent for suspension for Intravesical use Immunotherapy agent (BCG) for intravesical treatment of bladder cancer, supplied as powder and solvent for suspension.
• Mitomycin Powder and solvent for intravesical solution 10mg, 20mg, 40mg Chemotherapy drug (mitomycin) for intravesical bladder cancer treatment, available in 10mg, 20mg, and 40mg strengths.
• Gliolan® (5-ALA) Oral powder 1.5g Vial Photodynamic diagnostic agent (5-aminolevulinic acid, 1.5g vial) used in neurosurgery for fluorescence-guided resection of malignant glioma.
• ALFALYTE Oral Rehydration Solution Oral rehydration solution used for treating dehydration, distributed as a general sale item.
• Calphron® dietary supplement Phosphate binder dietary supplement containing 667mg of calcium acetate USP, distributed for renal dialysis patients.
• NephPlex® Rx Cost-effective prescription multivitamin for renal dialysis patients.
• MELCURA™ HoneyGel and HoneyGel Plus Medical device wound care product using medical-grade honey for burn and wound treatment, supplied as HoneyGel and HoneyGel Plus.
• Silverlon - Negative Pressure Dressing Silver-impregnated negative pressure wound therapy dressing for advanced wound care applications.
• Lubragel – Lubricating Gel for urethral Catheters Medical device lubricating gel for catheter insertion procedures (urethral catheters).
• Regulatory Affairs Services Multi-disciplinary regulatory affairs services including marketing authorization applications, eCTD dossier preparation, national labelling texts, artwork, multi-language translations (Arabic/Farsi/French/Urdu/English), lifecycle maintenance, variations, line extensions, renewals, and PSUR submissions for the MENA region. Delivered via the Centre of Regulatory Excellence (CoRE/MENA) in Dubai.
• Business Development and Market Access Services Regional representation and business development services including market analysis, sales and marketing strategy development, and tender business participation for non-registered medicines in MENA and Asian markets, delivered in partnership with Glomac Medical GmbH.

Named customers3 records

Segments4 records

Ideal customer profiles3 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

Ten partnerships are on record, tiered core, flagship and minor.

• BoryungcoreChannel Partner/ Reseller/ Distributor · 1 January 2022Exclusive agreement signed in 2022 for the UAE market. Collaboration established in 2021 for registering, marketing and supplying pharmaceutical products in UAE and the region. Kanarb is one of the leading products.
• Medac GmbHflagshipStrategic or Co-development Partner · 1 January 2008Long-standing partnership since 2008 for Sales and Business Development in UAE, Saudi Arabia, Qatar, Bahrain and Yemen markets. Established Centre of Regulatory Excellence (CoRE/MENA) in Dubai in 2012 for registration processing across MENA, Turkey, Sri Lanka, India and Pakistan. Over 15 years of fruitful collaboration.
• ALFA Lab (Lebanon)coreChannel Partner/ Reseller/ Distributor · 1 January 2007Exclusive marketing and distribution agreement for UAE market since 2007. ALFA is the largest Lebanese I.V solutions manufacturer, hemodialysis solutions, premixed hemodialysis powders and sodium bicarbonate cartridges producer. Celebrating 15+ years of successful partnership.
• Glomac Medical GmbH (Germany)coreStrategic or Co-development PartnerStrategic partnership for regional representation providing the best services in fast and sustainable market access into the MENA and some Asian markets. Combined expertise enables market analysis, business potential evaluation, and sales strategy development.
• PhotonamiccoreChannel Partner/ Reseller/ DistributorPartnership to supply Gliolan (5-ALA) in UAE and Saudi markets. Continuing strategic collaboration to enter neighboring markets to assist healthcare professionals in diagnosing and treating various medical conditions, particularly for Glioblastoma surgeries.
• Bioteck SPAcoreChannel Partner/ Reseller/ DistributorDistribution agreement for ChondroGrid in the UAE market, representing a new partnership for advancing orthopedic treatments.
• BoldMedminorChannel Partner/ Reseller/ DistributorPartnership focused on making world-class medical products available and affordable in UAE. Initial sales focus on medical dressings and topical agents for burn and wound care units in hospitals.
• Nephro-techminorChannel Partner/ Reseller/ DistributorUS-based pharmaceutical company providing high quality pharmaceuticals and supplements at affordable costs for Renal Dialysis. Product range includes Nephron FA and NephPlex Rx.
• PharmIdeaminorChannel Partner/ Reseller/ DistributorNew agreement announced for UAE market, representing a promising venture for growth opportunities.
• Istem MedikalminorChannel Partner/ Reseller/ DistributorRecently registered new medical device product which will support different healthcare providers to improve practice and make positive impact on patient lives.

Scale indicators5 records

Recent moves7 records

Expansion highlights5 records

Direct peers

• Ibn Sina Pharma: UAE-headquartered pharmaceutical distributor representing multiple international principals across the GCC region. Directly comparable as a UAE-rooted pharmaceutical distribution partner serving regional healthcare providers with in-licensed products.
• Life Pharma: UAE-headquartered pharmaceutical company marketing branded generics and specialty products across MENA. Closely comparable business model (in-licensing + marketing + regional distribution) and geography to Biotech Pharma.
• Genpharma: UAE specialty pharmaceutical company focused on niche therapy areas with regional distribution. Comparable to Biotech Pharma in the in-licensing plus specialty distribution model and MENA market focus.
• Neopharma: UAE-based pharmaceutical manufacturer and marketing company with regional MENA distribution across multiple therapeutic categories. Directly comparable in geographic focus, therapeutic breadth, and in-licensing plus distribution model to Biotech Pharma.
• City Pharmacy Co. UAE-based pharmaceutical importer and distributor serving healthcare providers across multiple therapeutic categories. Comparable business model and geography to Biotech Pharma's direct healthcare-provider distribution motion.

Broad incumbents

• Tabuk Pharmaceuticals: Saudi Arabia-based pharmaceutical manufacturer with branded generics and in-licensed specialty products distributed across MENA. Comparable therapeutic breadth and regional distribution focus, but with owned manufacturing and larger scale.
• Hikma Pharmaceuticals: MENA-origin multinational pharmaceutical company with branded, generic and injectable product portfolios across the Middle East and globally. Comparable as a regional pharma distributor serving the same therapeutic areas and MENA customer base, but at vastly larger scale.
• Julphar (Gulf Pharmaceutical Industries): UAE-headquartered pharmaceutical manufacturer and distributor with broad therapeutic coverage and regional GCC footprint. Comparable to Biotech Pharma as a UAE-based pharma distribution platform operating across similar geographies, but at significantly larger scale and with owned manufacturing.
• SPIMACO Addwaeih: Saudi Arabian pharmaceutical manufacturer and distributor with broad therapeutic coverage and regional reach. Comparable to Biotech Pharma as a regional specialty/generic pharma distribution platform serving GCC markets, but operating at materially larger scale.

Regional players

• Almed Pharma (Al Tafawoq): UAE specialty pharmaceutical distribution and marketing company focusing on in-licensed branded products. Comparable in-licensing-plus-distribution model and UAE base, but with different geographic emphasis.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks5 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/biotech-pharma-services

Revenue estimate

Valuation estimate

Number of profiles

Profiles1 record

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Biotech Pharma